Life-science briefing: Monday, March 17, 2008
TODAY’S HEADLINES:
Defibrillator maker Cameron Health takes in $14M (VBLS exclusive)
Miramar Labs gets $20M for “aesthetic” devices (VBLS exclusive)
Nellix raises $6.5M for aneurysm grafts (VBLS exclusive)
Vessel-clog remover Chestnut Medical pulls in $7.8M (VBLS exclusive)
Consumer genetics tester DNA Direct receives $7M (PDF release)
Precision Thera again prowling for venture funding (VentureWire)
Cancer-drug maker ChimeraCore raises $4.3M (VentureWire)
Kai Sensors pulls in $2.2M for radar-based sensors (VentureWire)
ProNAi raises $6M for DNA drugs, seeks $20M more (VentureWire)
(NOTE: Items on Cameron Health, Miramar Labs, Nellix and… Continue Reading
Life-science briefing: Thursday, March 6, 2008
TODAY’S HEADLINES:
France’s TxCell raises €11M for cell therapy (release)
Healthcare IT firm TriHealix takes in $7M (release)
Healthcare-software provider Anodyne Health acquires Piedmont Healthcare (release)
CEO, CFO resign at inhaled-drug biotech Topigen (release)
France’s TxCell raises €11M for cell therapy – TxCell, a French cell-therapy biotech, raised €10.5 million ($16 million) in a second funding round. Investors included Auriga Partners, AXA Private Equity, Bioam Gestion, CDC Innovation and Seventure.
The biotech is developing a patient-specific cell therapy for the gastrointestinal autoimmune… Continue Reading